Expression of chimeric HCV peptide in transgenic tobacco plants infected with recombinant alfalfa mosaic virus for development of a plant-derived vaccine against HCV
A.K. El Attar1,4*, A. M. Shamloul2, A.A. Shalaby1, B.Y. Riad3, A. Saad3, H.M. Mazyad1 and J.M. Keith1
1 Plant Pathology Research Institute, Agriculture Research Center, Giza, Egypt.
2Vaccine and Therapeutic Development Section, Fraunhofer Center for Molecular Biotechnology, Newark, DE, USA.
3Faculty of Science, Cairo University, Giza, Egypt.4National Institutes of Health, Vaccine and Therapeutic Section, Oral Infection and Immunity Branch, NIDCR, Bethesda, MD, USA.
Email: [email protected]